SpringWorks Therapeutics, Inc. Contracts & Agreements
46 Contracts & Agreements
- Business Finance (10 contracts)
- Business Operations (8)
- Human Resources (23)
- Intellectual Property (2)
- Real Estate (1)
- Uncategorized (2)
- Sales Agreement, dated February 27, 2024, by and between SpringWorks Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on February 27, 2024)
- Separation and Consulting Agreement, dated January 31, 2024, by and between L. Mary Smith and SpringWorks Therapeutics, Inc (Filed With SEC on February 2, 2024)
- Underwriting Agreement, dated as of December 4, 2023, among SpringWorks Therapeutics, Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Cowen and Company, LLC and... (Filed With SEC on December 6, 2023)
- Consulting and Separation Agreement, dated September 12, 2022, by and between Michael Burgess and SpringWorks Therapeutics, Inc (Filed With SEC on September 16, 2022)
- Registration Rights Agreement, dated as of September 7, 2022, among SpringWorks Therapeutics, Inc. and the investor parties thereto (Filed With SEC on September 8, 2022)
- Securities Purchase Agreement, dated as of September 7, 2022, among SpringWorks Therapeutics, Inc. and the investor parties thereto (Filed With SEC on September 8, 2022)
- Stock Purchase Agreement, dated September 6, 2022, by and between SpringWorks Therapeutics, Inc. and Glaxo Group Limited (Filed With SEC on September 7, 2022)
- Retention Agreement, dated May 2, 2022, by and between SpringWorks Therapeutics, Inc. and L. Mary Smith (Filed With SEC on May 5, 2022)
- Retention Agreement, dated (Filed With SEC on May 5, 2022)
- Second Lease Modification Agreement, dated as of January 31, 2022, by and between Two Harbor Point Square LLC and SpringWorks Therapeutics, Inc (Filed With SEC on May 5, 2022)
- Second Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 24, 2022)
- Amended and (Filed With SEC on February 24, 2022)
- Amendment No. 1 dated October 22, 2021, to the Clinical Trial Collaboration and Supply Agreement, dated as of June 25, 2019, between GlaxoSmithKline LLC and SpringWorks... (Filed With SEC on October 27, 2021)
- Amended and Restated Employment Agreement, dated as of July 30, 2021, by and between the Registrant and Herschel S. Weinstein (Filed With SEC on August 4, 2021)
- Amended and Restated Employment Agreement, dated as of July 30, 2021, by and between the Registrant and Daniel J. Pichl (Filed With SEC on August 4, 2021)
- Amended and Restated Employment Agreement, dated as of July 30, 2021, by and between the Registrant and L. Mary Smith (Filed With SEC on August 4, 2021)
- Amended and Restated Employment Agreement, dated as of July 30, 2021, by and between the Registrant and Michael Burgess (Filed With SEC on August 4, 2021)
- Amended and Restated Employment Agreement, dated as of July 30, 2021, by and between the Registrant and Bhavesh Ashar (Filed With SEC on August 4, 2021)
- Amended and Restated Employment Agreement, dated as of July 30, 2021, by and between the Registrant and Badreddin Edris (Filed With SEC on August 4, 2021)
- Amended and Restated Employment Agreement, dated as of July 30, 2021, by and between the Registrant and Francis I. Perier, Jr (Filed With SEC on August 4, 2021)
- Amended and Restated Employment Agreement, dated as of July 30, 2021, by and between the Registrant and Saqib Islam (Filed With SEC on August 4, 2021)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2021)
- Sales Agreement, dated February 25, 2021, by and between SpringWorks Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on February 25, 2021)
- Amendment to the Amended and Restated Investors Rights Agreement, dated as of February 25, 2021 (Filed With SEC on February 25, 2021)
- Underwriting Agreement, dated as of October 7, 2020, among SpringWorks Therapeutics, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Company, LLC, as... (Filed With SEC on October 8, 2020)
- Description of the Registrants Securities (Filed With SEC on March 12, 2020)
- Employment Agreement between SpringWorks Therapeutics, Inc and L. Mary Smith, dated October 10, 2019 (Filed With SEC on November 12, 2019)
- Employment Agreement between SpringWorks Therapeutics, Inc and Badreddin Edris, dated October 10, 2019 (Filed With SEC on November 12, 2019)
- Employment Agreement between SpringWorks Therapeutics, Inc and Jens Renstrup, dated October 10, 2019 (Filed With SEC on November 12, 2019)
- Employment Agreement between SpringWorks Therapeutics, Inc and Francis I. Perier, Jr., dated October 10, 2019 (Filed With SEC on November 12, 2019)
- Employment Agreement between SpringWorks Therapeutics, Inc and Saqib Islam, dated October 10, 2019 (Filed With SEC on November 12, 2019)
- Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated August 30, 2019 (Filed With SEC on September 3, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 3, 2019)
- 2019 Stock Option and Equity Incentive Plan and forms of award agreements thereunder (Filed With SEC on September 3, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on September 3, 2019)
- Termination Letter by and between SpringWorks Therapeutics Operating Company, Inc. and Daniel S. Lynch, dated August 16, 2019 (Filed With SEC on September 3, 2019)
- Form of Indemnification Agreement, by and between the Registrant and each of its Officers (Filed With SEC on August 16, 2019)
- Form of Indemnification Agreement, by and between the Registrant and each of its Directors (Filed With SEC on August 16, 2019)
- Non-Employee Director Compensation Policy (Filed With SEC on August 16, 2019)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on August 16, 2019)
- 2019 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on August 16, 2019)
- Specimen Common Stock Certificate of the Registrant (Filed With SEC on August 16, 2019)
- Amended and Restated License Agreement by and among the Registrant, Pfizer Inc., SpringWorks Subsidiary 2, Inc. and Pfizer Products, Inc., dated July 31, 2019 (Filed With SEC on August 16, 2019)
- Amended and Restated License Agreement by and among the Registrant, Pfizer Inc., SpringWorks Subsidiary 3, Inc. and Warner-Lambert Company LLC, dated August 7, 2019 (Filed With SEC on August 16, 2019)
- Clinical Collaboration Agreement by and among Springworks Subsidiary 3, PBC and BeiGene, Ltd., dated August 16, 2018 (Filed With SEC on August 16, 2019)
- Clinical Trial Collaboration and Supply Agreement by and between the Registrant and GlaxoSmithKline LLC, dated June 25, 2019 (Filed With SEC on August 16, 2019)
